Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 52.0 | 86 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 36.0 | 95 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 53.0 | 83 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 47.0 | 81 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | IL-2 | 45.5 | 66 | |
RA2159 | IL-6 | 100 | ug/mL | 3 | IL-2 | 64.0 | 75 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 63.0 | 69 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 59.0 | 60 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 55.0 | 82 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 59.0 | 107 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 51.0 | 86 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | IL-2 | 47.5 | 86 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | IL-2 | 57.0 | 98 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 53.0 | 85 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 55.0 | 77 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 55.5 | 90 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 53.5 | 88 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | IL-2 | 53.0 | 72 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | IL-2 | 49.0 | 79 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | IL-2 | 86.0 | 79 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-2 | 79.0 | 82 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-2 | 64.0 | 76 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-2 | 84.0 | 86 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-2 | 83.5 | 80 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-2 | 54.0 | 90 |